| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/26/2004 | CA2515022A1 Method for treating elevated intraocular pressure, including glaucoma |
| 08/26/2004 | CA2514720A1 Coated particles and pharmaceutical dosage forms |
| 08/26/2004 | CA2514650A1 Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
| 08/26/2004 | CA2457990A1 Personal care water-in-oil emulsion products |
| 08/25/2004 | EP1449533A1 Use of PVP-iodine liposomes for the treatment of acne |
| 08/25/2004 | EP1449531A2 Melt-extruded orally administrable opioid formulations |
| 08/25/2004 | EP1449530A2 Melt-extruded orally administrable opioid formulations |
| 08/25/2004 | EP1449528A1 Treatment of respiratory diseases |
| 08/25/2004 | EP1449527A2 Transdermal patch for administering a volatile liquid drug |
| 08/25/2004 | EP1449526A1 New UV-stable transdermal patch |
| 08/25/2004 | EP1449525A1 chewing gum in the form of multi-layer tablets |
| 08/25/2004 | EP1449524A1 Methods and devices for providing prolonged drug therapy |
| 08/25/2004 | EP1449523A1 Composition and method for stable injectable liquids |
| 08/25/2004 | EP1449522A1 A free radical quenching liposomal composition |
| 08/25/2004 | EP1449521A1 Use of PVP-iodine liposomes for treatment of atopic dermatitis |
| 08/25/2004 | EP1449520A1 Use of PVP-Iodine liposomes for treatment of herpes |
| 08/25/2004 | EP1448710A1 Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 08/25/2004 | EP1448709A1 Method for preparing gels |
| 08/25/2004 | EP1448707A1 Polymeric micelle composition with improved stability |
| 08/25/2004 | EP1448666A1 Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them |
| 08/25/2004 | EP1448604A1 Preparation method of solvent-free water-dispersible hydroxypropyl methyl cellulose phthalate nanoparticle |
| 08/25/2004 | EP1448558A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same |
| 08/25/2004 | EP1448456A1 Transdermal/transmucosal patch packaging |
| 08/25/2004 | EP1448353A2 Apparatus and method for manufacturing encapsulated products |
| 08/25/2004 | EP1448296A1 Gel capsules containing active ingredients and use thereof |
| 08/25/2004 | EP1448281A2 Therapeutic coating for an intravascular implant |
| 08/25/2004 | EP1448253A1 Transdermal transport device with suction |
| 08/25/2004 | EP1448235A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 08/25/2004 | EP1448234A1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 08/25/2004 | EP1448231A1 Topical delivery of codrugs |
| 08/25/2004 | EP1448228A2 Management of postoperative pain |
| 08/25/2004 | EP1448224A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 08/25/2004 | EP1448222A1 Biphasic mixtures of glp-1 and insulin |
| 08/25/2004 | EP1448221A1 Injection solution comprising an lhrh antagonist |
| 08/25/2004 | EP1448214A2 Ginger extract preparation |
| 08/25/2004 | EP1448209A2 A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 08/25/2004 | EP1448204A1 New dry and aqueous epinastine-syrup-formulation |
| 08/25/2004 | EP1448203A1 Pharmaceutical formulations comprising substituted xanthine compounds |
| 08/25/2004 | EP1448194A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 08/25/2004 | EP1448190A2 Salts formed of an at1-receptor antagonist and a cardiovascular agent |
| 08/25/2004 | EP1448182A1 Pharmaceutical compositions and methods for administering ep 2 receptor selective agonists |
| 08/25/2004 | EP1448175A1 Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate |
| 08/25/2004 | EP1448174A2 Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
| 08/25/2004 | EP1448173A2 A process for manufacture of a sustained release pharmaceutical composition containing microbeads of trimetazidine dihydrochloride |
| 08/25/2004 | EP1448172A1 Surface coated capsules |
| 08/25/2004 | EP1448171A2 Pharmaceutical formulation comprising more than 15% tamoxifen |
| 08/25/2004 | EP1448170A2 Efavirenz tablet formulation having unique biopharmaceutical characteristics |
| 08/25/2004 | EP1448169A1 Method for improving dissolution of poorly dispersible medicaments |
| 08/25/2004 | EP1448168A1 Pharmaceutical formulation comprising bicalutamide |
| 08/25/2004 | EP1448167A1 New use of ethoxylated phytosterols and phytostanols |
| 08/25/2004 | EP1448166A1 Controlled release polymeric compositions of bone growth promoting compounds |
| 08/25/2004 | EP1448165A2 Lipid carrier compositions and methods for improved drug retention |
| 08/25/2004 | EP1448151A1 Dosage form, device and methods of treatment |
| 08/25/2004 | EP1448127A1 Compositions for the treatment of infectious diseases |
| 08/25/2004 | EP1448116A1 Apparatus and methods for variably controlled substance delivery from implanted prostheses |
| 08/25/2004 | EP1448101A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| 08/25/2004 | EP1360957A4 Vitamin/mineral complex |
| 08/25/2004 | EP1289506B1 Process for producing a stable micronized composition of formoterol with a glucocorticosteroid |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1094790B1 Sustained release pharmaceutical preparation comprising phenytoin sodium |
| 08/25/2004 | EP1083881B1 LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents |
| 08/25/2004 | EP1037938B1 Use of hyperbranched polymers or dendrimers having a particular group as thickening or gelling agent |
| 08/25/2004 | EP1024796A4 Polymers containing antimicrobial agents and methods for making and using same |
| 08/25/2004 | EP0918541B1 Immunstimulating lipid formulation |
| 08/25/2004 | EP0881906B1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/25/2004 | EP0810853B1 Aerosols containing nanoparticle dispersions |
| 08/25/2004 | CN2635088Y Rapid biosealing hemostat |
| 08/25/2004 | CN1524125A 化合物 Compound |
| 08/25/2004 | CN1523998A Sustained-release compositions for injection and process for producing the same |
| 08/25/2004 | CN1523997A Stabilized interleukin 2 |
| 08/25/2004 | CN1523987A Immune response modifiers for the treatment of periodontal disease |
| 08/25/2004 | CN1523985A Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 08/25/2004 | CN1523984A Drug preparations |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523980A Pharmaceutical preparation comprising an active dispersed on a matrix |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523111A Secretion expressing type myocardium gene treating plasmid vector |
| 08/25/2004 | CN1523047A Method for preparing hydrophilic core/hydrophilic or hydrophobic shell functional macromolecule microballoon and corresponding microballoon product and application |
| 08/25/2004 | CN1523017A Oxfendazole chloride preparation and uses |
| 08/25/2004 | CN1523003A Novel 2-(alpha-hydroxyl amyl) and its preparing method and use |
| 08/25/2004 | CN1522759A Interferon and synergist combined pharmaceutical |
| 08/25/2004 | CN1522757A Muscular amino acid and peptide nucleoside powder injection and its preparation method |
| 08/25/2004 | CN1522755A Solid formulation containing isomaltone itol, its preparation method and uses |
| 08/25/2004 | CN1522750A Acne removing pill process and formulation |
| 08/25/2004 | CN1522746A Gadol pharmaceutical preparation, method for making same and uses |
| 08/25/2004 | CN1522745A Traditional Chinese medicine extract with anti-inflammatory action and promoting blood circulation function, and its preparation method |
| 08/25/2004 | CN1522744A Herb kalimeris indica infusion preparation method |
| 08/25/2004 | CN1522740A Hemiplegia hypertension and contraceptive treating plaster |
| 08/25/2004 | CN1522739A Bone fracture analgesic ointment |
| 08/25/2004 | CN1522736A Oral medication for treating psoriasis |
| 08/25/2004 | CN1522729A Acne eliminating cathartic pill preparation method |
| 08/25/2004 | CN1522728A Female health granule preparation method |
| 08/25/2004 | CN1522726A Novel schisandra fruit soft capsule formulation and its preparation method |
| 08/25/2004 | CN1522719A Pharmaceutical composition for treating rheumatism, rheumatoid arthritis and limb pains, and its preparation method |
| 08/25/2004 | CN1522716A Use of compound red-rooted salvia drop pills in preparation of leucocyte adherence prohibiting drug |
| 08/25/2004 | CN1522715A Use of compound red-rooted salvia drop pills in preparation of vascular permeability resistant drug |
| 08/25/2004 | CN1522714A Use of compound red-rooted salvia drop pills in preparation of mass cell degranulation prohibiting drug |
| 08/25/2004 | CN1522713A Use of compound red-rooted salvia drop pills in preparation of albumin leakage prohibiting drug |
| 08/25/2004 | CN1522711A Enterobacteria containing tablet |
| 08/25/2004 | CN1522710A Use of CoCl#-[2] in preparation of drug for treating leukemia |